ABS agreements in Thailand
This chapter focuses on 2 existing ABS agreements and the national legal context in which they have been developed. Although implementing rules under one of the national laws had not been passed until very recently (in mid-2013), agreements had been established with the permission of the relevant department (in the Shiseido case) and through a contract (in the Novartis case) according to mutually agreed terms (MAT) (in both cases). Monetary benefits are yet to be shared as research is continuing on the cosmetic and medicinal potential of the respective genetic resources. Having said that, it is worth examining the agreements as there are already some non-monetary benefits to be discussed from the collaborations that have been established.